Retsina Meyer

1 presentation

• T37. A PHASE IB STUDY EVALUATING SAFETY, PRELIMINARY EFFICACY, AND PUTATIVE BIOMARKERS OF NEUROPLASTICITY FOR THE NOVEL NEUROPLASTOGEN ZALSUPINDOLE (DLX-001) IN MAJOR DEPRESSIVE DISORDER

  2026 ASCP Annual Meeting